The LCZ696 and valsartan treatment of DCM rats significantly inhibited p-PERK (p < 0.001) and p-eIf2a protein levels (p < 0.01) in cardiac cells as compared to the untreated DCM animals. This evidence concerns the gene EIF2A and familial dilated cardiomyopathy.